2018
Intravesical device-assisted therapies for non-muscle-invasive bladder cancer
Tan W, Kelly J. Intravesical device-assisted therapies for non-muscle-invasive bladder cancer. Nature Reviews Urology 2018, 15: 667-685. PMID: 30254383, DOI: 10.1038/s41585-018-0092-z.Peer-Reviewed Original ResearchConceptsNon-muscle-invasive bladder cancerElectromotive drug administrationDevice-assisted therapiesBladder cancerHyperthermic chemotherapyDevice-assisted treatmentsIntravesical adjuvant treatmentHigh-risk diseaseResults of randomized trialsRisk of recurrenceRisk of progressionAlternative to BCGEffective treatment optionSingle-arm study designBladder cancer diagnosisBCG failureRandomized controlled trialsMaintenance regimensAdjuvant treatmentPatient cohortTreatment optionsRandomized trialsDrug AdministrationControlled trialsClinical guidelines
2016
Port-Site Metastases After Robotic Radical Cystectomy: A Systematic Review and Management Options
Khetrapal P, Tan W, Lamb B, Nathan S, Briggs T, Shankar A, Ramachandran N, Freeman A, Mitra A, Kelly J. Port-Site Metastases After Robotic Radical Cystectomy: A Systematic Review and Management Options. Clinical Genitourinary Cancer 2016, 15: 440-444. PMID: 28209455, DOI: 10.1016/j.clgc.2016.06.012.Peer-Reviewed Original ResearchConceptsRobot-assisted radical cystectomyPort-site metastasisRadical cystectomyCase of port-site metastasisLymph node-positive diseaseMuscle-invasive bladder cancerIntracorporeal robot-assisted radical cystectomySystematic reviewNode-positive diseaseSystematic review of MEDLINERobotic radical cystectomyIdentified 4 casesTreatment of chemotherapyReview of MEDLINEDisease-free statusSalvage chemotherapyPrimary tumorSurgical excisionMultimodal treatmentPublished studiesAggressive treatmentBladder cancerTreatment optionsEmbase databasesPatient factors